Next Article in Journal
Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against Trueperella pyogenes in Mice
Previous Article in Journal
Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 10
Issue 6
10.3390/vaccines10060840
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme

by
Ilhem Berrou
1,*,
Kathryn Hamilton
2,
Clare Cook
2,
Clare Armour
2,
Sian Hughes
3,
Jude Hancock
3,
Sally Quigg
3,
Huda Hajinur
4,
Seema Srivastava
2,
Charlie Kenward
3,
Amjid Ali
5,
Laura Hobbs
6,
Elena Milani
6 and
Nicola Walsh
1
1
Glenside Campus, School of Health and Social Wellbeing, University of the West of England, Bristol BS16 1DD, UK
2
South West England Public Health Training Scheme, First Floor, Park House, 1200 Bristol Parkway North, Newbrick Road, Bristol BS34 8YU, UK
3
National Health Service (NHS) Bristol, North Somerset and South Gloucestershire CCG, 360 Bristol, Marlborough Street, Bristol BS1 3NX, UK
4
Caafi Health, Unit 18, The Coach House, 2 Upper York Street, St Paul’s, Bristol BS2 8QN, UK
5
NHS Blood and Transplant 500, North Bristol Park, Filton, Bristol BS34 7QH, UK
6
Department of Applied Sciences, Frenchay Campus, University of the West of England, Bristol BS16 1QY, UK
*
Author to whom correspondence should be addressed.
Vaccines 2022, 10(6), 840; https://doi.org/10.3390/vaccines10060840
Submission received: 22 March 2022 / Revised: 10 May 2022 / Accepted: 19 May 2022 / Published: 25 May 2022
Browse Figures
Versions Notes

Abstract

The devastating impact of COVID-19 on individuals and communities has accelerated the development of vaccines and the deployment of ambitious vaccination programmes to reduce the risks of infection, infection transmission and symptom severity. However, many people delay or refuse to get vaccinated against COVID-19, for many complex reasons. Vaccination programmes that are tailored to address individual and communities’ COVID-19 concerns can improve vaccine uptake rates and help achieve the required herd-immunity threshold. The Maximising Uptake Programme has led to the vaccination of 7979 people from February–August 2021 in the South West of England, UK, who are at high risk of severe illness from COVID-19 and/or may not access the COVID-19 vaccines through mass vaccination centres and general practices. These include: people experiencing homelessness; non-English-speaking people; people from minority ethnic groups; refugees and asylum seekers; Gypsy, Roma, Travelers and boat people; and those who are less able to access vaccination centres, such as people with learning difficulties, serious mental illness, drug and alcohol dependence, people with physical and sensory impairment, and people with dementia. Outreach work coupled with a targeted communication and engagement campaign, co-designed with community leaders and influencers, have led to significant engagement and COVID-19 vaccine uptake among the target populations.
Keywords: COVID-19; vaccine hesitancy; minority ethnic groups; refugees; asylum seekers; Gypsy Roma Travelers communities; boat people; outreach vaccination; community-based interventions; community co-design COVID-19; vaccine hesitancy; minority ethnic groups; refugees; asylum seekers; Gypsy Roma Travelers communities; boat people; outreach vaccination; community-based interventions; community co-design

Share and Cite

MDPI and ACS Style

Berrou, I.; Hamilton, K.; Cook, C.; Armour, C.; Hughes, S.; Hancock, J.; Quigg, S.; Hajinur, H.; Srivastava, S.; Kenward, C.; et al. Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme. Vaccines 2022, 10, 840. https://doi.org/10.3390/vaccines10060840

AMA Style

Berrou I, Hamilton K, Cook C, Armour C, Hughes S, Hancock J, Quigg S, Hajinur H, Srivastava S, Kenward C, et al. Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme. Vaccines. 2022; 10(6):840. https://doi.org/10.3390/vaccines10060840

Chicago/Turabian Style

Berrou, Ilhem, Kathryn Hamilton, Clare Cook, Clare Armour, Sian Hughes, Jude Hancock, Sally Quigg, Huda Hajinur, Seema Srivastava, Charlie Kenward, and et al. 2022. "Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme" Vaccines 10, no. 6: 840. https://doi.org/10.3390/vaccines10060840

APA Style

Berrou, I., Hamilton, K., Cook, C., Armour, C., Hughes, S., Hancock, J., Quigg, S., Hajinur, H., Srivastava, S., Kenward, C., Ali, A., Hobbs, L., Milani, E., & Walsh, N. (2022). Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme. Vaccines, 10(6), 840. https://doi.org/10.3390/vaccines10060840

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop